250 related articles for article (PubMed ID: 36094767)
1. Bacteriophage as a potential therapy to control antibiotic-resistant Pseudomonas aeruginosa infection through topical application onto a full-thickness wound in a rat model.
Rezk N; Abdelsattar AS; Elzoghby D; Agwa MM; Abdelmoteleb M; Aly RG; Fayez MS; Essam K; Zaki BM; El-Shibiny A
J Genet Eng Biotechnol; 2022 Sep; 20(1):133. PubMed ID: 36094767
[TBL] [Abstract][Full Text] [Related]
2. Topically Applied Bacteriophage to Control Multi-Drug Resistant
Fayez MS; Hakim TA; Agwa MM; Abdelmoteleb M; Aly RG; Montaser NN; Abdelsattar AS; Rezk N; El-Shibiny A
Antibiotics (Basel); 2021 Aug; 10(9):. PubMed ID: 34572629
[TBL] [Abstract][Full Text] [Related]
3. Characterization of newly isolated bacteriophage to control multi-drug resistant Pseudomonas aeruginosa colonizing incision wounds in a rat model: in vitro and in vivo approach.
Abo Kamer AM; Abdelaziz AA; Nosair AM; Al-Madboly LA
Life Sci; 2022 Dec; 310():121085. PubMed ID: 36265569
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of a bacteriophage and its utilization against multi-drug resistant Pseudomonas aeruginosa-2995.
Jamal M; Andleeb S; Jalil F; Imran M; Nawaz MA; Hussain T; Ali M; Das CR
Life Sci; 2017 Dec; 190():21-28. PubMed ID: 28964812
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of bacteriophage to control multidrug-resistant Pseudomonas aeruginosa planktonic cells and biofilm.
Adnan M; Ali Shah MR; Jamal M; Jalil F; Andleeb S; Nawaz MA; Pervez S; Hussain T; Shah I; Imran M; Kamil A
Biologicals; 2020 Jan; 63():89-96. PubMed ID: 31685418
[TBL] [Abstract][Full Text] [Related]
6. Isolation of a bacteriophage targeting Pseudomonas aeruginosa and exhibits a promising in vivo efficacy.
Abdelghafar A; El-Ganiny A; Shaker G; Askoura M
AMB Express; 2023 Jul; 13(1):79. PubMed ID: 37495819
[TBL] [Abstract][Full Text] [Related]
7. Topically applied bacteriophage to control multi-drug resistant
Wang J; Meng W; Zhang K; Wang J; Lu B; Wang R; Jia K
Front Microbiol; 2022; 13():1031101. PubMed ID: 36329839
[No Abstract] [Full Text] [Related]
8. Therapeutic effect and anti-biofilm ability assessment of a novel phage, phiPA1-3, against carbapenem-resistant Pseudomonas aeruginosa.
Tsai YC; Lee YP; Lin NT; Yang HH; Teh SH; Lin LC
Virus Res; 2023 Oct; 335():199178. PubMed ID: 37490958
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Development of a Bacteriophage Cocktail for Treating Multidrug Resistant
Camens S; Liu S; Hon K; Bouras GS; Psaltis AJ; Wormald PJ; Vreugde S
Microorganisms; 2021 Sep; 9(9):. PubMed ID: 34576896
[TBL] [Abstract][Full Text] [Related]
10. [Biological characteristics and genomic information of a bacteriophage against pan-drug resistant
Qi ZY; Yang SY; Dong SW; Zhao FF; Qin JH; Xiang J
Zhonghua Shao Shang Za Zhi; 2020 Jan; 36(1):14-23. PubMed ID: 32023713
[No Abstract] [Full Text] [Related]
11. Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice.
Vinodkumar CS; Kalsurmath S; Neelagund YF
Indian J Pathol Microbiol; 2008; 51(3):360-6. PubMed ID: 18723958
[TBL] [Abstract][Full Text] [Related]
12. [Susceptibilities of multidrug-resistant pathogens responsible for complicated skin and soft tissue infections to standard bacteriophage cocktails].
Gündoğdu A; Kılıç H; Ulu Kılıç A; Kutateladze M
Mikrobiyol Bul; 2016 Apr; 50(2):215-23. PubMed ID: 27175494
[TBL] [Abstract][Full Text] [Related]
13. Successful Intratracheal Treatment of Phage and Antibiotic Combination Therapy of a Multi-Drug Resistant
Duplessis C; Warawa JM; Lawrenz MB; Henry M; Biswas B
Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34438996
[TBL] [Abstract][Full Text] [Related]
14. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
[TBL] [Abstract][Full Text] [Related]
15. Use of Phage Cocktail BFC 1.10 in Combination With Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant
Racenis K; Rezevska D; Madelane M; Lavrinovics E; Djebara S; Petersons A; Kroica J
Front Med (Lausanne); 2022; 9():851310. PubMed ID: 35547216
[TBL] [Abstract][Full Text] [Related]
16. Isolation and Characterization of Bacteriophages Active against
Mohamed WF; Askora AA; Mahdy MMH; El-Hussieny EA; Abu-Shady HM
Arch Razi Inst; 2022 Dec; 77(6):2187-2200. PubMed ID: 37274914
[TBL] [Abstract][Full Text] [Related]
17. Phage-resistant
Wannasrichan W; Htoo HH; Suwansaeng R; Pogliano J; Nonejuie P; Chaikeeratisak V
Front Microbiol; 2022; 13():1004733. PubMed ID: 36274728
[No Abstract] [Full Text] [Related]
18. Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against
Rossitto M; Fiscarelli EV; Rosati P
Front Microbiol; 2018; 9():775. PubMed ID: 29780361
[TBL] [Abstract][Full Text] [Related]
19. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa.
Wang J; Hu B; Xu M; Yan Q; Liu S; Zhu X; Sun Z; Reed E; Ding L; Gong J; Li QQ; Hu J
Int J Mol Med; 2006 Feb; 17(2):309-17. PubMed ID: 16391831
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a Broad-Host-Range Lytic Phage SHWT1 Against Multidrug-Resistant
Tao C; Yi Z; Zhang Y; Wang Y; Zhu H; Afayibo DJA; Li T; Tian M; Qi J; Ding C; Gao S; Wang S; Yu S
Front Vet Sci; 2021; 8():683853. PubMed ID: 34179174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
